Comprehensive prediction of robust synthetic lethality between paralog pairs in cancer cell lines

Barbara De Kegel1, Niall Quinn1, Nicola A Thompson2

  • 1School of Computer Science, University College Dublin, Dublin, Ireland; Systems Biology Ireland, University College Dublin, Dublin, Ireland.

Cell Systems
|September 16, 2021
PubMed

Insights

Synthetic lethality between gene paralogs offers a promising cancer therapy strategy. Researchers developed a machine learning model to predict which paralog pairs are synthetic lethal, improving cancer gene targeting.

Area of Science:

  • Genomics
  • Cancer Biology
  • Computational Biology

Background:

  • Paralogs, genes with shared ancestry, can exhibit synthetic lethality, a concept exploitable for cancer treatment.
  • Current understanding of synthetic lethal interactions between human paralogs is limited, with only a fraction of pairs investigated.
  • Targeting gene loss in cancer through synthetic lethality is a potentially broad therapeutic approach.

Purpose of the Study:

  • To identify features predicting synthetic lethality between paralog pairs.
  • To develop a machine learning model for predicting and explaining paralog-pair synthetic lethality.
  • To assess the predictive accuracy and specificity of the developed model.

Main Methods:

  • Analysis of genome-wide CRISPR screens and molecular profiles from over 700 cancer cell lines.
  • Identification of predictive features for synthetic lethality, including shared protein-protein interactions and evolutionary conservation.
  • Development and validation of a machine learning classifier to predict synthetic lethal paralog pairs.

Main Results:

  • Identified key features predictive of synthetic lethality between paralogs.
  • Developed a machine learning classifier that accurately predicts synthetic lethality in combinatorial CRISPR screens.
  • The classifier can differentiate between universally synthetic lethal pairs and those specific to certain cell lines.

Conclusions:

  • Machine learning models can effectively predict synthetic lethality between gene paralogs.
  • This approach enhances the potential for broad application of synthetic lethality in cancer therapy.
  • Predictive models can guide the selection of paralog pairs for targeted cancer treatments.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.4K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
481
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K